BC
ELV icon

Bridgefront Capital’s Elevance Health ELV Stock Holding History

Bridgefront Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,632
Closed -$1.36M – 585
2026
Q1 		$1.36M Buy
+4,632
New +$1.52M 0.34% 80
2025
Q4 		– Sell
-1,905
Closed -$616K – 597
2025
Q3 		$616K Buy
+1,905
New +$592K 0.18% 189
2024
Q4 		– Sell
-632
Closed -$329K – 637
2024
Q3 		$329K Buy
+632
New +$338K 0.13% 294
2023
Q3 		– Sell
-1,702
Closed -$756K – 448
2023
Q2 		$756K Buy
1,702
+606
+55% +$280K 0.41% 48
2023
Q1 		$504K Buy
+1,096
New +$522K 0.31% 104

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bridgefront Capital's ELV Position: Q2 2026 in Review

Bridgefront Capital sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 4,632 shares — an estimated $1.36M sold.

Bridgefront Capital first reported a position in ELV in Q1 2023 and held it in 5 quarters. The position peaked at $1.36M in Q1 2026. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Bridgefront Capital reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Bridgefront Capital sold 4,632 Elevance Health shares in Q2 2026, an estimated $1.36M.
  • Bridgefront Capital first reported a position in Elevance Health in Q1 2023 and held it in 5 quarters.
  • Bridgefront Capital's Elevance Health position peaked at $1.36M in Q1 2026.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.